Back to Results
First PageMeta Content
Organic chemistry / Phenols / Piperidines / Eli Lilly and Company / Raloxifene / Tamoxifen / Menopause / Breast cancer / Cancer / Medicine / Chemistry / Selective estrogen receptor modulators


National Cancer Institute www.cancer.gov NSABP http://www.nsabp.pitt.edu or http://foundation.nsabp.org
Add to Reading List

Document Date: 2006-04-17 10:35:11


Open Document

File Size: 58,09 KB

Share Result on Facebook

City

Atlanta / Wilmington / Indianapolis / /

Company

Eli Lilly and Company / The STAR / AstraZeneca Pharmaceuticals / Bowel Project / /

/

Facility

National Cancer Institute / /

IndustryTerm

Cancer Prevention / raloxifene / tamoxifen / breast cancer prevention / media materials / prevention of non-invasive breast cancers / /

MedicalCondition

uterine cancer / noninvasive breast cancers / strokes / DCIS / uncontrolled hypertension / ductal carcinoma / uncontrolled diabetes / transient ischemic attack / blood clots / heart attacks / mainly endometrial cancer / non-invasive breast cancers / especially endometrial cancers / breast cancer / largest breast cancer / cancer / disease / pulmonary embolisms / stroke / percent fewer uterine cancers / invasive breast cancers / Uterine cancers / invasive breast cancer / deep vein thrombosis / percent fewer blood clots / osteoporosis / atrial fibrillation / lobular carcinoma / percent fewer deep vein thromboses / cataract / /

MedicalTreatment

placebos / hysterectomy / /

Organization

National Cancer Institute / NCI’s Division of Cancer Prevention / Lori Garvey NSABP Operations Center / NCI's STAR / American Society for Clinical Oncology / Bowel Project / /

Person

Leslie Ford / John E. Niederhuber / Sandra J. Horning / Norman Wolmark / Lori Garvey / /

/

Position

associate director for clinical research / president / chairman / /

Product

Evista / Nolvadex / /

ProvinceOrState

Indiana / Delaware / /

PublishedMedium

the ASCO annual / /

URL

http /

SocialTag